Chest
Volume 111, Issue 6, Supplement, June 1997, Pages 82S-83S
Journal home page for Chest

The Presence of Genetic Anticipation Suggests That the Molecular Basis of Familial Primary Pulmonary Hypertension May Be Trinucleotide Repeat Expansion

https://doi.org/10.1378/chest.111.6_Supplement.82SGet rights and content

REFERENCE (1)

  • NicholsWC et al.

    Localization of the gene for familial primary pulmonary hypertension to chromosome 2q31-32 [letter].

    Nat Genet

    (1997)

Cited by (24)

  • The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: Results from a multicenter study of European Caucasian patients

    2009, Human Immunology
    Citation Excerpt :

    The roles of CCL2 have been thoroughly investigated and it has found that its biologic activities extend beyond that of chemo-attraction as it can also directly induce cell activation and fibrosis. In this light, CCL2 has been demonstrated to be upregulated in a variety of fibrotic conditions including idiopathic pulmonary fibrosis, systemic sclerosis, and bleomycine-induced experimental scleroderma [1–4]. In addition, the direct role of CCL2 in the fibrotic process has been further substantiated by the observations that CCL2 is able to directly increase type I collagen gene expression by the modulation of TGFβ expression [5], and that mice lacking CCL2 receptor (CCR2) are protected from fluorescein isothiocynate- and bleomycine-induced lung fibrosis [6].

  • Pulmonary Arterial Hypertension

    2006, Vascular Medicine: A Companion to Braunwald's Heart Disease
  • Pulmonary arterial hypertension

    2006, Vascular Medicine
  • Foreword

    2006, Pulmonary Vascular Disease
  • The pathology of pulmonary arterial hypertension

    2002, Current Diagnostic Pathology
View all citing articles on Scopus

Supported by National Institutes of Health, National Heart, Lung, and Blood Institute grants HL 48164 and HL 07123.

View full text